United States General Surgery Market Outlook to 2025 – Access Instruments, Aesthetic Devices, Aesthetic Lasers and Energy Devices and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995

GlobalData’s “United States General Surgery Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States General Surgery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Access Instruments, Aesthetic Devices, Aesthetic Lasers and Energy Devices, Bariatric Surgery Devices, Biopsy Devices, Bronchoscopes, Chest Drainage Catheters and Units, Colonoscopes, Cystoscopes, Duodenoscopes, Embolization Particles, Endoscopy Fluid Management Systems, Endoscopy Visualization Systems and Components, Esophagoscopes & Gastroscopes, Gynecological Devices, Hernia Repair Devices, Hysteroscopes, Laparoscopes, Laryngoscope Blades & Handles, Laryngoscopes, Non-Vascular Stents, Resectoscopes, Robotic Surgery, Sigmoidoscopes, Sterilization Equipment, Surgical Energy Devices, Surgical Stapling Devices and Ureteroscopes.

The United States General Surgery Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for General Surgery Market.
• Global corporate-level profiles of key companies operating within the United States General Surgery Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States General Surgery is segmented as follows:

• Access Instruments

• Aesthetic Devices

• Aesthetic Lasers and Energy Devices

• Bariatric Surgery Devices

• Biopsy Devices

• Bronchoscopes

• Chest Drainage Catheters and Units

• Colonoscopes

• Cystoscopes

• Duodenoscopes

• Embolization Particles

• Endoscopy Fluid Management Systems

• Endoscopy Visualization Systems and Components

• Esophagoscopes & Gastroscopes

• Gynecological Devices

• Hernia Repair Devices

• Hysteroscopes

• Laparoscopes

• Laryngoscope Blades & Handles

• Laryngoscopes

• Non-Vascular Stents

• Resectoscopes

• Robotic Surgery

• Sigmoidoscopes

• Sterilization Equipment

• Surgical Energy Devices

• Surgical Stapling Devices

• Ureteroscopes

Reasons to Buy

Key Reasons to Purchase – The United States General Surgery Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United States General Surgery Market Outlook to 2025” report:
• Olympus Corp
• KARL STORZ SE & Co KG
• PENTAX Medical Co

Table of Contents

1 Table of Contents 2

1.1 List of Tables 14

1.2 List of Figures 27

2 Introduction 32

2.1 What Is This Report About? 32

2.2 General Surgery Market Segmentation 32

2.3 Definitions of Markets Covered in the Report 37

3 General Surgery Market, United States 62

3.1 General Surgery Market, United States, Revenue ($m), 2015-2025 62

3.2 General Surgery Market, United States, Revenue Mix ($m), 2019 65

3.3 General Surgery Market, United States, Category Contribution by Revenue ($m), 2019 66

3.4 General Surgery Market, United States, Revenue ($m), 2015-2025 69

3.5 General Surgery Market, United States, Volume (Units), 2015-2025 76

3.6 General Surgery Market, United States, Volume (Units), 2015-2025 79

3.7 General Surgery Market, United States, Company Share by Revenue ($m), 2019 86

4 Access Instruments Market, United States 88

4.1 Access Instruments Market, United States, Revenue Mix ($m), 2019 88

4.2 Access Instruments Market, United States, Segment Contribution (%), 2019 89

4.3 Access Instruments Market, United States, Revenue ($m), 2015-2025 90

4.3.1 Retractors Market, United States, Revenue ($m), by Segment, 2015-2025 92

4.3.2 Trocars Market, United States, Revenue ($m), by Segment, 2015-2025 94

4.4 Access Instruments Market, United States, Volume (Units), 2015-2025 96

4.4.1 Retractors Market, United States, Volume (Units), by Segment, 2015-2025 98

4.4.2 Trocars Market, United States, Volume (Units), by Segment, 2015-2025 100

4.5 Access Instruments Market, United States, Average Price ($), 2015-2025 102

4.6 Access Instruments Market, United States, Distribution Share by Revenue ($m), 2019 103

4.7 Access Instruments Market, United States, Company Share by Revenue ($m), 2019 104

5 Aesthetic Devices Market, United States 106

5.1 Aesthetic Devices Market, United States, Revenue Mix ($m), 2019 106

5.2 Aesthetic Devices Market, United States, Segment Contribution (%), 2019 107

5.3 Aesthetic Devices Market, United States, Revenue ($m), 2015-2025 108

5.3.1 Aesthetic Fillers Market, United States, Revenue ($m), by Segment, 2015-2025 110

5.3.2 Aesthetic Implants Market, United States, Revenue ($m), by Segment, 2015-2025 112

5.4 Aesthetic Devices Market, United States, Volume (Units), 2015-2025 114

5.4.1 Aesthetic Fillers Market, United States, Volume (Units), by Segment, 2015-2025 116

5.4.2 Aesthetic Implants Market, United States, Volume (Units), by Segment, 2015-2025 118

5.5 Aesthetic Devices Market, United States, Average Price ($), 2015-2025 120

5.6 Aesthetic Devices Market, United States, Distribution Share by Revenue ($m), 2019 122

5.7 Aesthetic Devices Market, United States, Company Share by Revenue ($m), 2019 123

6 Aesthetic Lasers and Energy Devices Market, United States 125

6.1 Aesthetic Lasers and Energy Devices Market, United States, Revenue Mix ($m), 2019 125

6.2 Aesthetic Lasers and Energy Devices Market, United States, Segment Contribution (%), 2019 126

6.3 Aesthetic Lasers and Energy Devices Market, United States, Revenue ($m), 2015-2025 127

6.3.1 Laser Resurfacing Devices Market, United States, Revenue ($m), by Segment, 2015-2025 129

6.3.2 Minimally Invasive Body Contouring Devices Market, United States, Revenue ($m), by Segment, 2015-2025 131

6.3.3 Non Invasive Body Contouring Devices Market, United States, Revenue ($m), by Segment, 2015-2025 134

6.4 Aesthetic Lasers and Energy Devices Market, United States, Volume (Units), 2015-2025 136

6.4.1 Laser Resurfacing Devices Market, United States, Volume (Units), by Segment, 2015-2025 138

6.4.2 Minimally Invasive Body Contouring Devices Market, United States, Volume (Units), by Segment, 2015-2025 140

6.4.3 Non Invasive Body Contouring Devices Market, United States, Volume (Units), by Segment, 2015-2025 143

6.5 Aesthetic Lasers and Energy Devices Market, United States, Average Price ($) , 2015-2025 145

6.6 Aesthetic Lasers and Energy Devices Market, United States, Distribution Share by Revenue ($m), 2019 147

6.7 Aesthetic Lasers and Energy Devices Market, United States, Company Share by Revenue ($m), 2019 148

7 Bariatric Surgery Devices Market, United States 150

7.1 Bariatric Surgery Devices Market, United States, Revenue Mix ($m), 2019 150

7.2 Bariatric Surgery Devices Market, United States, Segment Contribution (%), 2019 151

7.3 Bariatric Surgery Devices Market, United States, Revenue ($m), 2015-2025 152

7.4 Bariatric Surgery Devices Market, United States, Volume (Units), 2015-2025 154

7.5 Bariatric Surgery Devices Market, United States, Average Price ($), 2015-2025 156

7.6 Bariatric Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2019 157

7.7 Bariatric Surgery Devices Market, United States, Company Share by Revenue ($m), 2019 158

8 Biopsy Devices Market, United States 159

8.1 Biopsy Devices Market, United States, Revenue Mix ($m), 2019 159

8.2 Biopsy Devices Market, United States, Segment Contribution (%), 2019 160

8.3 Biopsy Devices Market, United States, Revenue ($m), 2015-2025 161

8.3.1 Biopsy Core Needles & Devices Market, United States, Revenue ($m), by Segment, 2015-2025 164

8.3.2 Biopsy Fine Aspiration Needles & Devices Market, United States, Revenue ($m), by Segment, 2015-2025 166

8.3.3 Biopsy Forceps Market, United States, Revenue ($m), by Segment, 2015-2025 168

8.3.4 Biopsy Guns & Needles Market, United States, Revenue ($m), by Segment, 2015-2025 170

8.3.5 Biopsy Punches Market, United States, Revenue ($m), by Segment, 2015-2025 172

8.4 Biopsy Devices Market, United States, Volume (Units), 2015-2025 174

8.4.1 Biopsy Core Needles & Devices Market, United States, Volume (Units), by Segment, 2015-2025 177

8.4.2 Biopsy Fine Aspiration Needles & Devices Market, United States, Volume (Units), by Segment, 2015-2025 179

8.4.3 Biopsy Forceps Market, United States, Volume (Units), by Segment, 2015-2025 181

8.4.4 Biopsy Guns & Needles Market, United States, Volume (Units), by Segment, 2015-2025 183

8.4.5 Biopsy Punches Market, United States, Volume (Units), by Segment, 2015-2025 185

8.5 Biopsy Devices Market, United States, Average Price ($) , 2015-2025 187

8.6 Biopsy Devices Market, United States, Distribution Share by Revenue ($m), 2019 189

8.7 Biopsy Devices Market, United States, Company Share by Revenue ($m), 2019 190

9 Bronchoscopes Market, United States 192

9.1 Bronchoscopes Market, United States, Revenue Mix ($m), 2019 192

9.2 Bronchoscopes Market, United States, Segment Contribution (%), 2019 193

9.3 Bronchoscopes Market, United States, Revenue ($m), 2015-2025 194

9.3.1 Non-Video Bronchoscopes Market, United States, Revenue ($m), by Segment, 2015-2025 196

9.3.2 Video Bronchoscopes Market, United States, Revenue ($m), by Segment, 2015-2025 198

9.4 Bronchoscopes Market, United States, Volume (Units), 2015-2025 200

9.4.1 Non-Video Bronchoscopes Market, United States, Volume (Units), by Segment, 2015-2025 202

9.4.2 Video Bronchoscopes Market, United States, Volume (Units), by Segment, 2015-2025 204

9.5 Bronchoscopes Market, United States, Average Price ($), 2015-2025 206

9.6 Bronchoscopes Market, United States, Distribution Share by Revenue ($m), 2019 207

9.7 Bronchoscopes Market, United States, Company Share by Revenue ($m), 2019 208

10 Chest Drainage Catheters and Units Market, United States 210

10.1 Chest Drainage Catheters and Units Market, United States, Revenue Mix ($m), 2019 210

10.2 Chest Drainage Catheters and Units Market, United States, Segment Contribution (%), 2019 211

10.3 Chest Drainage Catheters and Units Market, United States, Revenue ($m), 2015-2025 212

10.3.1 Chest Drainage Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 214

10.4 Chest Drainage Catheters and Units Market, United States, Volume (Units), 2015-2025 216

10.4.1 Chest Drainage Catheters Market, United States, Volume (Units), by Segment, 2015-2025 218

10.5 Chest Drainage Catheters and Units Market, United States, Average Price ($), 2015-2025 220

10.6 Chest Drainage Catheters and Units Market, United States, Distribution Share by Revenue ($m), 2019 221

10.7 Chest Drainage Catheters and Units Market, United States, Company Share by Revenue ($m), 2019 222

11 Colonoscopes Market, United States 224

11.1 Colonoscopes Market, United States, Revenue Mix ($m), 2019 224

11.2 Colonoscopes Market, United States, Segment Contribution (%), 2019 225

11.3 Colonoscopes Market, United States, Revenue ($m), 2015-2025 226

11.4 Colonoscopes Market, United States, Volume (Units), 2015-2025 228

11.5 Colonoscopes Market, United States, Average Price ($), 2015-2025 230

11.6 Colonoscopes Market, United States, Distribution Share by Revenue ($m), 2019 231

11.7 Colonoscopes Market, United States, Company Share by Revenue ($m), 2019 232

12 Cystoscopes Market, United States 233

12.1 Cystoscopes Market, United States, Revenue Mix ($m), 2019 233

12.2 Cystoscopes Market, United States, Segment Contribution (%), 2019 234

12.3 Cystoscopes Market, United States, Revenue ($m), 2015-2025 235

12.3.1 Non-Video (Fibre) Cystoscopes Market, United States, Revenue ($m), by Segment, 2015-2025 237

12.4 Cystoscopes Market, United States, Volume (Units), 2015-2025 239

12.4.1 Non-Video (Fibre) Cystoscopes Market, United States, Volume (Units), by Segment, 2015-2025 241

12.5 Cystoscopes Market, United States, Average Price ($), 2015-2025 243

12.6 Cystoscopes Market, United States, Distribution Share by Revenue ($m), 2019 244

12.7 Cystoscopes Market, United States, Company Share by Revenue ($m), 2019 245

13 Duodenoscopes Market, United States 246

13.1 Duodenoscopes Market, United States, Revenue ($m), 2015-2025 246

13.2 Duodenoscopes Market, United States, Volume (Units), 2015-2025 248

13.3 Duodenoscopes Market, United States, Average Price ($), 2015-2025 250

13.4 Duodenoscopes Market, United States, Distribution Share by Revenue ($m), 2019 251

13.5 Duodenoscopes Market, United States, Company Share by Revenue ($m), 2019 252

14 Embolization Particles Market, United States 253

14.1 Embolization Particles Market, United States, Revenue Mix ($m), 2019 253

14.2 Embolization Particles Market, United States, Segment Contribution (%), 2019 254

14.3 Embolization Particles Market, United States, Revenue ($m), 2015-2025 255

14.4 Embolization Particles Market, United States, Volume (Units), 2015-2025 257

14.5 Embolization Particles Market, United States, Average Price ($) , 2015-2025 259

14.6 Embolization Particles Market, United States, Distribution Share by Revenue ($m), 2019 260

14.7 Embolization Particles Market, United States, Company Share by Revenue ($m), 2019 261

15 Endoscopy Fluid Management Systems Market, United States 263

15.1 Endoscopy Fluid Management Systems Market, United States, Revenue Mix ($m), 2019 263

15.2 Endoscopy Fluid Management Systems Market, United States, Segment Contribution (%), 2019 264

15.3 Endoscopy Fluid Management Systems Market, United States, Revenue ($m), 2015-2025 265

15.4 Endoscopy Fluid Management Systems Market, United States, Volume (Units), 2015-2025 268

15.5 Endoscopy Fluid Management Systems Market, United States, Average Price ($), 2015-2025 271

15.6 Endoscopy Fluid Management Systems Market, United States, Distribution Share by Revenue ($m), 2019 272

15.7 Endoscopy Fluid Management Systems Market, United States, Company Share by Revenue ($m), 2019 273

16 Endoscopy Visualization Systems and Components Market, United States 275

16.1 Endoscopy Visualization Systems and Components Market, United States, Revenue Mix ($m), 2019 275

16.2 Endoscopy Visualization Systems and Components Market, United States, Segment Contribution (%), 2019 276

16.3 Endoscopy Visualization Systems and Components Market, United States, Revenue ($m), 2015-2025 277

16.3.1 Endoscopy Visualization System Components Market, United States, Revenue ($m), by Segment, 2015-2025 279

16.3.2 Endoscopy Visualization Systems Market, United States, Revenue ($m), by Segment, 2015-2025 282

16.4 Endoscopy Visualization Systems and Components Market, United States, Volume (Units), 2015-2025 284

16.4.1 Endoscopy Visualization System Components Market, United States, Volume (Units), by Segment, 2015-2025 286

16.4.2 Endoscopy Visualization Systems Market, United States, Volume (Units), by Segment, 2015-2025 289

16.5 Endoscopy Visualization Systems and Components Market, United States, Average Price ($), 2015-2025 291

16.6 Endoscopy Visualization Systems and Components Market, United States, Distribution Share by Revenue ($m), 2019 293

16.7 Endoscopy Visualization Systems and Components Market, United States, Company Share by Revenue ($m), 2019 294

17 Esophagoscopes & Gastroscopes Market, United States 296

17.1 Esophagoscopes & Gastroscopes Market, United States, Revenue Mix ($m), 2019 296

17.2 Esophagoscopes & Gastroscopes Market, United States, Segment Contribution (%), 2019 297

17.3 Esophagoscopes & Gastroscopes Market, United States, Revenue ($m), 2015-2025 298

17.3.1 Flexible Gastroscopes Market, United States, Revenue ($m), by Segment, 2015-2025 300

17.4 Esophagoscopes & Gastroscopes Market, United States, Volume (Units), 2015-2025 302

17.4.1 Flexible Gastroscopes Market, United States, Volume (Units), by Segment, 2015-2025 304

17.5 Esophagoscopes & Gastroscopes Market, United States, Average Price ($) , 2015-2025 306

17.6 Esophagoscopes & Gastroscopes Market, United States, Distribution Share by Revenue ($m), 2019 307

17.7 Esophagoscopes & Gastroscopes Market, United States, Company Share by Revenue ($m), 2019 308

18 Gynecological Devices Market, United States 309

18.1 Gynecological Devices Market, United States, Revenue Mix ($m), 2019 309

18.2 Gynecological Devices Market, United States, Segment Contribution (%), 2019 310

18.3 Gynecological Devices Market, United States, Revenue ($m), 2015-2025 311

18.3.1 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2015-2025 313

18.3.2 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2015-2025 316

18.4 Gynecological Devices Market, United States, Volume (Units), 2015-2025 318

18.4.1 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2015-2025 320

18.4.2 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2015-2025 323

18.5 Gynecological Devices Market, United States, Average Price ($), 2015-2025 325

18.6 Gynecological Devices Market, United States, Distribution Share by Revenue ($m), 2019 327

18.7 Gynecological Devices Market, United States, Company Share by Revenue ($m), 2019 328

19 Hernia Repair Devices Market, United States 330

19.1 Hernia Repair Devices Market, United States, Revenue Mix ($m), 2019 330

19.2 Hernia Repair Devices Market, United States, Segment Contribution (%), 2019 331

19.3 Hernia Repair Devices Market, United States, Revenue ($m), 2015-2025 332

19.3.1 Synthetic Meshes Market, United States, Revenue ($m), by Segment, 2015-2025 335

19.4 Hernia Repair Devices Market, United States, Volume (Units), 2015-2025 337

19.4.1 Synthetic Meshes Market, United States, Volume (Units), by Segment, 2015-2025 340

19.5 Hernia Repair Devices Market, United States, Average Price ($), 2015-2025 342

19.6 Hernia Repair Devices Market, United States, Distribution Share by Revenue ($m), 2019 344

19.7 Hernia Repair Devices Market, United States, Company Share by Revenue ($m), 2019 345

20 Hysteroscopes Market, United States 347

20.1 Hysteroscopes Market, United States, Revenue Mix ($m), 2019 347

20.2 Hysteroscopes Market, United States, Segment Contribution (%), 2019 348

20.3 Hysteroscopes Market, United States, Revenue ($m), 2015-2025 349

20.3.1 Non-Video (Fibre) Hysteroscopes Market, United States, Revenue ($m), by Segment, 2015-2025 351

20.4 Hysteroscopes Market, United States, Volume (Units), 2015-2025 353

20.4.1 Non-Video (Fibre) Hysteroscopes Market, United States, Volume (Units), by Segment, 2015-2025 355

20.5 Hysteroscopes Market, United States, Average Price ($), 2015-2025 357

20.6 Hysteroscopes Market, United States, Distribution Share by Revenue ($m), 2019 358

20.7 Hysteroscopes Market, United States, Company Share by Revenue ($m), 2019 359

21 Laparoscopes Market, United States 361

21.1 Laparoscopes Market, United States, Revenue Mix ($m), 2019 361

21.2 Laparoscopes Market, United States, Segment Contribution (%), 2019 362

21.3 Laparoscopes Market, United States, Revenue ($m), 2015-2025 363

21.3.1 Video Laparoscopes Market, United States, Revenue ($m), by Segment, 2015-2025 365

21.4 Laparoscopes Market, United States, Volume (Units), 2015-2025 367

21.4.1 Video Laparoscopes Market, United States, Volume (Units), by Segment, 2015-2025 369

21.5 Laparoscopes Market, United States, Average Price ($) , 2015-2025 371

21.6 Laparoscopes Market, United States, Distribution Share by Revenue ($m), 2019 372

21.7 Laparoscopes Market, United States, Company Share by Revenue ($m), 2019 373

22 Laryngoscope Blades & Handles Market, United States 374

22.1 Laryngoscope Blades & Handles Market, United States, Revenue Mix ($m), 2019 374

22.2 Laryngoscope Blades & Handles Market, United States, Segment Contribution (%), 2019 375

22.3 Laryngoscope Blades & Handles Market, United States, Revenue ($m), 2015-2025 376

22.3.1 Laryngoscope Blades Market, United States, Revenue ($m), by Segment, 2015-2025 378

22.3.2 Laryngoscope Handles Market, United States, Revenue ($m), by Segment, 2015-2025 380

22.4 Laryngoscope Blades & Handles Market, United States, Volume (Units), 2015-2025 382

22.4.1 Laryngoscope Blades Market, United States, Volume (Units), by Segment, 2015-2025 384

22.4.2 Laryngoscope Handles Market, United States, Volume (Units), by Segment, 2015-2025 386

22.5 Laryngoscope Blades & Handles Market, United States, Average Price ($), 2015-2025 388

22.6 Laryngoscope Blades & Handles Market, United States, Distribution Share by Revenue ($m), 2019 389

22.7 Laryngoscope Blades & Handles Market, United States, Company Share by Revenue ($m), 2019 390

23 Laryngoscopes Market, United States 392

23.1 Laryngoscopes Market, United States, Revenue Mix ($m), 2019 392

23.2 Laryngoscopes Market, United States, Segment Contribution (%), 2019 393

23.3 Laryngoscopes Market, United States, Revenue ($m), 2015-2025 394

23.3.1 Non-Video Laryngoscopes Market, United States, Revenue ($m), by Segment, 2015-2025 396

23.3.2 Video Laryngoscopes Market, United States, Revenue ($m), by Segment, 2015-2025 398

23.4 Laryngoscopes Market, United States, Volume (Units), 2015-2025 400

23.4.1 Non-Video Laryngoscopes Market, United States, Volume (Units), by Segment, 2015-2025 402

23.4.2 Video Laryngoscopes Market, United States, Volume (Units), by Segment, 2015-2025 404

23.5 Laryngoscopes Market, United States, Average Price ($), 2015-2025 406

23.6 Laryngoscopes Market, United States, Distribution Share by Revenue ($m), 2019 407

23.7 Laryngoscopes Market, United States, Company Share by Revenue ($m), 2019 408

24 Non-Vascular Stents Market, United States 410

24.1 Non-Vascular Stents Market, United States, Revenue Mix ($m), 2019 410

24.2 Non-Vascular Stents Market, United States, Segment Contribution (%), 2019 411

24.3 Non-Vascular Stents Market, United States, Revenue ($m), 2015-2025 412

24.3.1 Airway Stents Market, United States, Revenue ($m), by Segment, 2015-2025 415

24.3.2 Enteral Stents Market, United States, Revenue ($m), by Segment, 2015-2025 417

24.3.3 Pancreatic and Biliary Stents Market, United States, Revenue ($m), by Segment, 2015-2025 419

24.3.4 Urinary Tract Stents Market, United States, Revenue ($m), by Segment, 2015-2025 421

24.4 Non-Vascular Stents Market, United States, Volume (Units), 2015-2025 423

24.4.1 Airway Stents Market, United States, Volume (Units), by Segment, 2015-2025 426

24.4.2 Enteral Stents Market, United States, Volume (Units), by Segment, 2015-2025 428

24.4.3 Pancreatic and Biliary Stents Market, United States, Volume (Units), by Segment, 2015-2025 430

24.4.4 Urinary Tract Stents Market, United States, Volume (Units), by Segment, 2015-2025 432

24.5 Non-Vascular Stents Market, United States, Average Price ($) , 2015-2025 434

24.6 Non-Vascular Stents Market, United States, Distribution Share by Revenue ($m), 2019 436

24.7 Non-Vascular Stents Market, United States, Company Share by Revenue ($m), 2019 437

25 Resectoscopes Market, United States 439

25.1 Resectoscopes Market, United States, Revenue ($m), 2015-2025 439

25.2 Resectoscopes Market, United States, Volume (Units), 2015-2025 441

25.3 Resectoscopes Market, United States, Average Price ($), 2015-2025 443

25.4 Resectoscopes Market, United States, Distribution Share by Revenue ($m), 2019 444

25.5 Resectoscopes Market, United States, Company Share by Revenue ($m), 2019 445

26 Robotic Surgery Market, United States 447

26.1 Robotic Surgery Market, United States, Revenue Mix ($m), 2019 447

26.2 Robotic Surgery Market, United States, Segment Contribution (%), 2019 448

26.3 Robotic Surgery Market, United States, Revenue ($m), 2015-2025 449

26.4 Robotic Surgery Market, United States, Volume (Units), 2015-2025 451

26.5 Robotic Surgery Market, United States, Average Price ($), 2015-2025 453

26.6 Robotic Surgery Market, United States, Distribution Share by Revenue ($m), 2019 454

26.7 Robotic Surgery Market, United States, Company Share by Revenue ($m), 2019 455

27 Sigmoidoscopes Market, United States 456

27.1 Sigmoidoscopes Market, United States, Revenue Mix ($m), 2019 456

27.2 Sigmoidoscopes Market, United States, Segment Contribution (%), 2019 457

27.3 Sigmoidoscopes Market, United States, Revenue ($m), 2015-2025 458

27.3.1 Non-Video (Fibre) Sigmoidoscopes Market, United States, Revenue ($m), by Segment, 2015-2025 460

27.4 Sigmoidoscopes Market, United States, Volume (Units), 2015-2025 462

27.4.1 Non-Video (Fibre) Sigmoidoscopes Market, United States, Volume (Units), by Segment, 2015-2025 464

27.5 Sigmoidoscopes Market, United States, Average Price ($), 2015-2025 466

27.6 Sigmoidoscopes Market, United States, Distribution Share by Revenue ($m), 2019 467

27.7 Sigmoidoscopes Market, United States, Company Share by Revenue ($m), 2019 468

28 Sterilization Equipment Market, United States 469

28.1 Sterilization Equipment Market, United States, Revenue Mix ($m), 2019 469

28.2 Sterilization Equipment Market, United States, Segment Contribution (%), 2019 470

28.3 Sterilization Equipment Market, United States, Revenue ($m), 2015-2025 471

28.3.1 Chemical Sterilizers Market, United States, Revenue ($m), by Segment, 2015-2025 473

28.3.2 Physical Sterilizers Market, United States, Revenue ($m), by Segment, 2015-2025 475

28.4 Sterilization Equipment Market, United States, Volume (Units), 2015-2025 477

28.4.1 Chemical Sterilizers Market, United States, Volume (Units), by Segment, 2015-2025 479

28.4.2 Physical Sterilizers Market, United States, Volume (Units), by Segment, 2015-2025 481

28.5 Sterilization Equipment Market, United States, Average Price ($), 2015-2025 483

28.6 Sterilization Equipment Market, United States, Distribution Share by Revenue ($m), 2019 485

28.7 Sterilization Equipment Market, United States, Company Share by Revenue ($m), 2019 486

29 Surgical Energy Devices Market, United States 488

29.1 Surgical Energy Devices Market, United States, Revenue Mix ($m), 2019 488

29.2 Surgical Energy Devices Market, United States, Segment Contribution (%), 2019 489

29.3 Surgical Energy Devices Market, United States, Revenue ($m), 2015-2025 490

29.3.1 Surgical Energy Generators Market, United States, Revenue ($m), by Segment, 2015-2025 492

29.3.2 Surgical Energy Instruments Market, United States, Revenue ($m), by Segment, 2015-2025 495

29.4 Surgical Energy Devices Market, United States, Volume (Units), 2015-2025 497

29.4.1 Surgical Energy Generators Market, United States, Volume (Units), by Segment, 2015-2025 499

29.4.2 Surgical Energy Instruments Market, United States, Volume (Units), by Segment, 2015-2025 502

29.5 Surgical Energy Devices Market, United States, Average Price ($) , 2015-2025 504

29.6 Surgical Energy Devices Market, United States, Distribution Share by Revenue ($m), 2019 506

29.7 Surgical Energy Devices Market, United States, Company Share by Revenue ($m), 2019 507

30 Surgical Stapling Devices Market, United States 509

30.1 Surgical Stapling Devices Market, United States, Revenue Mix ($m), 2019 509

30.2 Surgical Stapling Devices Market, United States, Segment Contribution (%), 2019 510

30.3 Surgical Stapling Devices Market, United States, Revenue ($m), 2015-2025 511

30.3.1 External Surgical Stapling Devices Market, United States, Revenue ($m), by Segment, 2015-2025 513

30.3.2 Internal Surgical Stapling Devices Market, United States, Revenue ($m), by Segment, 2015-2025 515

30.4 Surgical Stapling Devices Market, United States, Volume (Units), 2015-2025 518

30.4.1 External Surgical Stapling Devices Market, United States, Volume (Units), by Segment, 2015-2025 520

30.4.2 Internal Surgical Stapling Devices Market, United States, Volume (Units), by Segment, 2015-2025 522

30.5 Surgical Stapling Devices Market, United States, Average Price ($) , 2015-2025 525

30.6 Surgical Stapling Devices Market, United States, Distribution Share by Revenue ($m), 2019 527

30.7 Surgical Stapling Devices Market, United States, Company Share by Revenue ($m), 2019 528

31 Ureteroscopes Market, United States 529

31.1 Ureteroscopes Market, United States, Revenue Mix ($m), 2019 529

31.2 Ureteroscopes Market, United States, Segment Contribution (%), 2019 530

31.3 Ureteroscopes Market, United States, Revenue ($m), 2015-2025 531

31.3.1 Non-Video (Fibre) Ureteroscopes Market, United States, Revenue ($m), by Segment, 2015-2025 533

31.4 Ureteroscopes Market, United States, Volume (Units), 2015-2025 535

31.4.1 Non-Video (Fibre) Ureteroscopes Market, United States, Volume (Units), by Segment, 2015-2025 537

31.5 Ureteroscopes Market, United States, Average Price ($), 2015-2025 539

31.6 Ureteroscopes Market, United States, Distribution Share by Revenue ($m), 2019 540

31.7 Ureteroscopes Market, United States, Company Share by Revenue ($m), 2019 541

32 Overview of Key Companies in United States, General Surgery Market 542

32.1 Olympus Corp 542

32.1.1 Company Overview 542

32.2 KARL STORZ SE & Co KG 542

32.2.1 Company Overview 542

32.3 PENTAX Medical Co 542

32.3.1 Company Overview 542

32.4 Boston Scientific Corp 542

32.4.1 Company Overview 542

32.5 Medtronic Plc 543

32.5.1 Company Overview 543

32.6 Stryker Corp 543

32.6.1 Company Overview 543

32.7 Johnson & Johnson 543

32.7.1 Company Overview 543

32.8 ERBE Elektromedizin GmbH 543

32.8.1 Company Overview 543

32.9 AngioDynamics Inc 544

32.9.1 Company Overview 544

32.10 Intuitive Surgical Inc 544

32.10.1 Company Overview 544

32.11 Getinge AB 544

32.11.1 Company Overview 544

32.12 Ethicon Inc 544

32.12.1 Company Overview 544

32.13 Mentor Worldwide LLC 545

32.13.1 Company Overview 545

32.14 Merz Pharma GmbH & Co KgaA 545

32.14.1 Company Overview 545

32.15 Allergan Ltd 545

32.15.1 Company Overview 545

32.16 B. Braun Melsungen AG 545

32.16.1 Company Overview 545

32.17 CR Bard Inc 546

32.17.1 Company Overview 546

32.18 ConMed Corp 546

32.18.1 Company Overview 546

33 General Surgery Market Pipeline Products 547

34 Financial Deals Landscape 551

34.1 Acquisition 551

34.1.1 Respiratory Technology Acquires Somna Therapeutics 551

34.1.2 Pantheon Spinal Acquires Incite Innovation 552

34.1.3 Conventus Orthopaedics Acquires Flower Orthopedics 553

34.1.4 Medtronic Acquires Digital Surgery 554

34.1.5 Nextremity Solutions to Acquire Lakeland Technology 556

34.1.6 Symmetry Surgical Acquires O.R. Company 557

34.1.7 Anika Therapeutics Acquires Parcus Medical 558

34.1.8 Anika Therapeutics Acquires Arthrosurface 560

34.1.9 Johnson & Johnson Acquires Remaining Joint Venture Stake in Verb Surgical from Verily Life Sciences 562

34.1.10 Laborie Medical Acquires Clinical Innovations 564

34.1.11 Vivo Capital May Sell Surgical Specialties for USD500 Million 566

34.1.12 Canon Acquires 70% Stake in Quality ElectroDynamics 567

34.1.13 Marmon Acquires 60% Stake in Colson Medical Companies from Colson Associates 568

34.1.14 Viant Medical Acquires Meraqi Medical 570

34.1.15 Integra LifeSciences Acquires Rebound Therapeutics 571

34.1.16 Stryker Acquires Mobius Imaging and GYS Tech (Cardan Robotics) 572

34.2 Asset Transactions 574

34.2.1 Minerva Surgical Acquires Intrauterine Health Products from Boston Scientific 574

34.2.2 Sharp Fluidics Acquires neoClose from neoSurgical 576

34.2.3 OraSure Technologies Sells its Cryosurgical Systems Business to CryoConcepts for up to USD12 Million 577

34.3 Debt Offerings 578

34.3.1 PAVmed Raises USD7 Million in Private Placement of

7.875% Notes Due 2022 578

34.3.2 Evolus to Raise USD40 Million in Private Placement of 3% Convertible Notes Due 2025 579

34.3.3 Invo Bioscience to Raise USD1 Million in Second Tranche of Private Placement of Notes 580

34.3.4 Abbott Laboratories Raises USD650 Million in Public Offering of

1.4% Notes Due 2030 581

34.3.5 Abbott Laboratories Raises USD650 Million in Public Offering of

1.15% Notes Due 2028 583

34.3.6 CryoLife Prices Private Placement of

4.250% Notes Due 2025 for USD100 Million 585

34.3.7 GI Dynamics Raises USD0.75 Million in Private Placement of 5% Convertible Promissory Note 587

34.3.8 Stryker Raises USD650 Million in Public Offering of

1.15% Notes Due 2025 588

34.3.9 Stryker Raises USD1 Billion in Public Offering of

1.95% Notes Due 2030 590

34.3.10 Stryker Raises USD650 Million in Public Offering of

2.9% Notes Due 2050 592

34.3.11 Teleflex Prices Private Placement of

4.25% Notes Due 2028 for USD500 Million 594

34.3.12 Invo Bioscience Raises USD2.1 Million in First Tranche of Private Placement of Notes 595

34.3.13 Cantel Medical Raises USD168 Million in Private Placement of

3.25% Notes Due 2025 596

34.3.14 Boston Scientific Raises USD1.2 Billion in Public Offering of

2.65% Senior Notes due 2030 598

34.3.15 Boston Scientific Raises USD500 Million in Public Offering of

1.9% Senior Notes due 2025 600

34.3.16 Danaher Raises USD163.4 Million in Public Offering of

1.7% Senior Notes Due 2024 602

34.3.17 Danaher Raises USD327 Million in Public Offering of

2.1% Senior Notes Due 2026 604

34.3.18 Danaher Raises USD327 Million in Public Offering of

2.5% Senior Notes Due 2030 606

34.3.19 Baxter International Raises USD500 Million in Private Placement of

3.95% Senior Notes Due 2030 608

34.3.20 Baxter International Raises USD750 Million in Private Placement of

3.75% Senior Notes Due 2025 609

34.3.21 Danaher Raises USD810.2 Million in Public Offering of

1.700% Senior Notes Due 2024 610

34.3.22 Danaher Raises USD540 Million in Public Offering of

2.100% Senior Notes Due 2026 612

34.3.23 Danaher Raises USD540 Million in Public Offering of

2.500% Senior Notes Due 2030 614

34.3.24 Zimmer Biomet Prices Public Offering of

3.55% Notes Due 2030 for USD900 Million 616

34.3.25 Zimmer Biomet Prices Public Offering of

3.05% Notes Due 2026 for USD600 Million 618

34.3.26 Sientra Raises USD60 Million in Private Placement of Convertible Notes 620

34.3.27 Integra LifeSciences Prices Private Placement of

0.5% Convertible Senior Notes Due 2025 for USD500 Million 622

34.3.28 MRI Interventions Raises USD17.5 Million in Private Placement of Notes 624

34.3.29 Stryker Raises USD826.2 Million in Public Offering of 1% Notes Due 2031 626

34.3.30 Stryker Raises USD881.3 Million in Public Offering of

0.75% Notes Due 2029 628

34.3.31 Stryker Raises USD936.4 Million in Public Offering of

0.25% Notes Due 2024 630

34.3.32 Zimmer Biomet Prices Public Offering of

1.164% Notes Due 2027 for USD553 Million 632

34.3.33 AbbVie Raises USD750 Million in Private Placement of Floating Rate Notes Due 2021 634

34.3.34 AbbVie Raises USD750 Million in Private Placement of Floating Rate Notes Due 2022 636

34.3.35 AbbVie Raises USD1.75 Billion in Private Placement of

2.150% Notes Due 2021 637

34.3.36 AbbVie Raises USD3 Billion in Private Placement of

2.300% Notes Due 2022 638

34.3.37 AbbVie Raises USD3.75 Billion in Private Placement of

2.600% Notes Due 2024 639

34.3.38 AbbVie Raises USD4 Billion in Private Placement of

2.95% Notes Due 2026 640

34.3.39 AbbVie Raises USD5.5 Billion in Private Placement of

3.2% Notes Due 2029 642

34.3.40 AbbVie Raises USD4 Billion in Private Placement of

4.050% Notes Due 2039 643

34.3.41 AbbVie Raises USD5.75 Billion in Private Placement of

4.250% Notes Due 2049 644

34.3.42 Boston Scientific Raises USD999.2 Million in Public Offering of

0.625% Notes Due 2027 645

34.3.43 AbbVie Raises USD750 Million in Private Placement of Senior Floating Rate Notes Due 2021 647

34.3.44 Danaher Raises USD700 Million in Public Offering of

2.05% Senior Notes Due 2022 649

34.3.45 Danaher Raises USD700 Million in Public Offering of

2.2% Senior Notes Due 2024 651

34.3.46 Danaher Raises USD900 Million in Public Offering of

3.25% Senior Notes Due 2039 653

34.3.47 Danaher Raises USD900 Million in Public Offering of

3.4% Senior Notes Due 2049 655

34.3.48 Danaher Raises USD800 Million in Public Offering of

2.6% Senior Notes Due 2029 657

34.3.49 CranioVation Raises USD0.46 Million in Debt Offering 659

34.3.50 AbbVie Raises USD719.6 Million in Public Offering of

1.25% Notes Due 2031 660

34.3.51 AbbVie Raises USD830.3 Million in Public Offering of

0.75% Notes Due 2027 662

34.3.52 PerkinElmer Raises USD850 Million in Public Offering of

3.3% Notes Due 2029 664

34.3.53 Hill-Rom (Hillrom) to Raise USD425 Million in Private Placement of Notes 666

34.3.54 Danaher Raises USD1.37 Billion in Public Offering of

1.35% Notes Due 2039 667

34.3.55 Danaher Raises USD1.92 Billion in Public Offering of

0.75% Notes Due 2031 669

34.3.56 Danaher Raises USD823 Million in Public Offering of

1.8% Notes Due 2049 671

34.3.57 Danaher Raises USD1.37 Billion in Public Offering of

0.2% Notes Due 2026 673

34.3.58 Danaher Raises USD1.37 Billion in Public Offering of

0.45% Notes Due 2028 675

34.3.59 GI Dynamics to up to Raise USD4.6 Million in Private Placement of Convertible Note and Warrant 677

34.4 Equity Offerings 679

34.4.1 Akers Biosciences Prices USD6.8 Million in Private Placement of Shares 679

34.4.2 Cytosorbents Prices Public Offering of Shares for USD50 Million 680

34.4.3 NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD50 Million 682

34.4.4 Apollo Endosurgery to Raise USD25 Million in Private Placement of Shares and Pre-Funded Warrants 683

34.4.5 Ra Medical Systems Raises USD12 Million in Upsized Public Offering of Units 684

34.4.6 ACell to Raise up to USD80 Million in IPO of Shares 686

34.4.7 Innovation Pharma Files Registration Statement for Public Offering of Securities up to USD60 Million 688

34.4.8 Biolase Raises USD18 Million in Rights Offering of Units 690

34.4.9 TransEnterix Raises USD15 Million in Public Offering of Shares 692

34.4.10 Soliton Prices Public Offering of Shares for USD35 Million 694

34.4.11 Avita Medical to Raise Funds in Public Offering of Shares 696

34.4.12 TELA Bio Raises USD48 Million in Public Offering of Shares 697

34.4.13 Repro-Med Systems Prices Public Offering of Shares for USD25 Million 699

34.4.14 Biolase Raises USD6.9 Million in Private Placement of Shares and Warrants 701

34.4.15 CHF Solutions Plans to Raise Funds through Public Offering of Common Stock 703

34.4.16 Hamilton Thorne Raises USD5 Million in Private Placement of Shares 704

34.4.17 Boston Scientific Raises USD1 Billion in Public Offering of Shares 705

34.4.18 Boston Scientific Raises USD1 Billion in Public Offering of

5.5% Mandatory Convertible Preferred Stock 707

34.4.19 Lemaitre Vascular Files Registration Statement for Public Offering of Securities for up to USD200 Million 709

34.4.20 Akers Biosciences Raises USD4.8 Million in Private Placement of Shares 711

34.4.21 AtriCure Prices Public Offering of Shares for USD175 Million 712

34.4.22 Danaher Raises USD1.55 Billion in Public Offering of Shares 714

34.4.23 Danaher Raises USD1.71 Billion in Public Offering of Series B Convertible Preferred Stock 716

34.4.24 Immunomedics Raises USD483 Million in Public Offering of Shares 718

34.4.25 Cutera Raises USD28.8 Million in Public Offering of Shares 720

34.4.26 Inspire Medical Systems Raises USD133.3 Million in Public Offering of Shares 722

34.4.27 Akers Biosciences Prices Private Placement of Shares for USD4.6 Million 724

34.4.28 iCAD Plans to Raise up to USD25 Million in Public Offering of Shares 725

34.4.29 Akers Biosciences Raises USD1.2 Million in Equity Offering 726

34.4.30 CHF Solutions Raises USD1.3 Million in Private Placement of Shares and Warrants 727

34.4.31 TransEnterix Prices Public Offering of Units for USD15 Million 729

34.4.32 SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock 731

34.4.33 Rockwell Medical Prices Public Offering of Shares for USD7.5 Million 732

34.4.34 TransEnterix Files Registration Statement for Public Offering of Securities for up to USD150 Million 734

34.4.35 Establishment Labs Raises USD69 Million in Public Offering of Shares 735

34.4.36 CHF Solutions Raises USD9.66 Million in Public Offering 737

34.4.37 Misonix Prices Public Offering of Shares for USD30 Million 739

34.4.38 SI-Bone Prices USD92.45 Million Public Offeirng of Shares 741

34.4.39 NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million 743

34.4.40 InMode Aesthetic Solutions May Raise Funds through Public Offering of Shares 745

34.4.41 Immunomedics Raises USD287.5 Million in Public Offering of Shares 746

34.4.42 ViewRay Raises USD149.5 Million in Public Offering of Shares 748

34.4.43 Akers Biosciences to Raise Funds through Public Offering of Units 750

34.4.44 Organogenesis Prices USD45 Million Public Offering of Shares 751

34.4.45 Surgical Center of Connecticut Raises USD0.005 Million in Equity Financing 753

34.4.46 Avita Medical Raises USD15.4 Million in Private Placement of Shares 754

34.4.47 SI-Bone Plans to Raise up to USD200 Million in Public Offering of Securities 755

34.4.48 TELA Bio Raises USD52 Million in IPO of Shares 756

34.4.49 Evolus Raises USD78 Million in Public Offering of Shares 758

34.4.50 CHF Solutions Raises USD1.4 Million in Private Placement of Shares 760

34.4.51 Akers Biosciences Raises USD8 Million in Public Offering of Shares 761

34.4.52 Precision Optics Files for Public Offering of Shares 763

34.4.53 Biolase Raises USD4 Million in Private Placement of Preferred Shares 764

34.4.54 CHF Solutions Raises USD0.7 Million in Private Placement of Shares 766

34.4.55 Biolase Raises USD4.5 Million in Public Offering of Shares 767

34.4.56 Soliton to Raise USD6.3 Million in Private Placement of Shares and Warrants 769

34.4.57 Ideal Implant Raises USD3.93 Million in Equity Financing 770

34.4.58 Drive DeVilbiss Healthcare Raises USD35 Million in Financing Round 771

34.4.59 Viveve Medical Files Registration Statement for Public Offering of Units for up to USD8 Million 772

34.4.60 TransEnterix Prices Public Offering of Shares for USD20.3 Million 774

34.4.61 Organogenesis Plans to Raise up to USD100 Million in Public Offering of Securities 776

34.4.62 GI Dynamics Raises USD2 Million in First Tranche of Private Placement of CHESS Depositary Interests, upon Exercise of Warrants 777

34.5 Grants 779

34.5.1 Bedside ultrasound system for 3D guidance of bone marrow aspiration and biopsy procedures 779

34.5.2 First and Only Soft Tissue Support Device to Improve Patient Experience and System Cost in Breast Reconstruction 780

34.5.3 Percutaneous Ultrasound Gastrostomy (PUG): Engineering and Feasibility Assessment of a Pediatric Device 781

34.5.4 Prospective evaluation of a surgical solution for breast cancer-associated lymphedema 782

34.5.5 Optically Sensorized, Actuated Needles for Oncological Applications 783

34.5.6 An Augmented Reality Device to Prevent Wrong-Level Spine Surgery 784

34.5.7 Soft Tissue Characterization in Urogynecological Surgery 785

34.5.8 Commercialization of an Ultrasound-guided Vascular Access Device 786

34.6 Merger 787

34.6.1 Salter Labs and SunMed Holdings Merge 787

34.7 Partnerships 788

34.7.1 Ceek Women’s Health and Lupin Pharma Enter into Marketing Agreement 788

34.7.2 Olympus Medical Systems Enters into Distribution Agreement with UVision360 789

34.7.3 Suneva Medical Enters into Partnership with Sinclair Pharma 790

34.7.4 Caresyntax Expands its Agreement with Diversified Imagination 791

34.7.5 SeaSpine and 7D Surgical Enter into Agreement 792

34.7.6 Cartessa Aesthetics Enters into Distribution Agreement with DEKA 793

34.7.7 Olympus Enters into Distribution Agreement with Rocamed 794

34.7.8 Cook Medical and Quanta System Enter into Distribution Agreement 795

34.8 Private Equity 796

34.8.1 NuView Life Sciences to Raise USD90 Million in Financing 796

34.8.2 GI Dynamics to Raise USD10 Million in Private Placement of Shares 797

34.8.3 MiMedx to Raise USD100 Million in Private Equity Financing 799

34.8.4 Inverness Graham Invests in Catheter and Medical Design 801

34.8.5 Meditrina Raises USD10 Million in Equity Financing 802

34.8.6 AbbVie Recommends Shareholders to Reject Mini-Tender Offer of TRC Capital 803

34.8.7 Decathlon Capital Partners Invests in Cirtec Medical 805

34.8.8 Rockwell Medical to Raise USD15 Million in Private Financing 806

34.8.9 TransEnterix to Raise up to USD25 Million in Financing 807

34.8.10 Obalon Therapeutics to Raise up to USD15 Million in Financing 808

34.8.11 Montagu Private Equity Acquires OEM Business from RTI Surgical for USD440 Million 810

34.8.12 Gelesis Raises USD63.4 Million in Financing 812

34.8.13 Corre Partners and Legion Partners Invests USD100 Million in NN 813

34.8.14 Clayton, Dubilier & Rice Acquires Cynosure from Hologic for USD205 Million 815

34.9 Venture Financing 817

34.9.1 Mission Bio Raises USD70 Million in Series C Financing 817

34.9.2 Fractyl Laboratories Raises USD55 Million in Series E Financing 819

34.9.3 Fractyl Labs Raises USD55 Million in Series E Financing 821

34.9.4 Spine Align Raises USD1.5 Million in Venture Financing 823

34.9.5 Proprio Vision Raises USD23 Million in Series A Financing 824

34.9.6 Precise Light Surgical Raises USD0.02 Million in Venture Financing 825

34.9.7 HistoSonics Raises USD40 Million in Series C-1 Financing 826

34.9.8 Neuro-Kinesis Raises USD0.05 Million in Venture Financing 828

34.9.9 Zurex Pharma Raises USD7.5 Million in Venture Financing 829

34.9.10 Neuro-Kinesis Raises USD0.05 Million in Venture Financing 830

34.9.11 CapsoVision Raises USD0.98 Million in Venture Financing 831

34.9.12 Allotrope Medical Raises Funds through Venture Financing 832

34.9.13 Suneva Medical Raises USD25.1 Million in Venture Financing 833

34.9.14 CARLSMED Raises Additional USD1.5 Million in Venture Financing 834

34.9.15 Thermedical Raises Additional USD8 Million in Venture Financing 835

34.9.16 TAS Medical Raises USD0.6 Million in Venture Financing 836

34.9.17 Biolectrics Raises USD0.52 Million in Venture Financing 837

34.9.18 Alume Biosciences Raises USD5.5 Million in Series A Financing 838

34.9.19 Surgical Innovation Associates Raises USD1.7 Million in Venture Financing 839

34.9.20 AccuVein Raises USD2.6 Million in Venture Financing 840

34.9.21 LifeSprout Raises USD28.5 Million in Series A Financing 841

34.9.22 Ideal Implant Raises USD3 Million in Venture Financing 843

34.9.23 Vortex Surgical Raises Additional USD0.7 Million in Venture Financing 844

34.9.24 Precision Optics Raises USD0.3 Million in Venture Financing 845

34.9.25 Origami Surgical Raises USD2.22 Million in Venture Financing 846

34.9.26 Lodestone Biomedical Raises USD0.11 Million in Venture Financing 847

34.9.27 Centerline Biomedical Raises USD10 Million in Venture Financing 848

34.9.28 Fractyl Labs Raises USD44.8 Million in Venture Financing 849

34.9.29 Viseon Raises USD18 Million in Series B Financing 850

34.9.30 InterRad Medical Raises Additional USD3.5 Million in Venture Financing 851

34.9.31 Nanovis Raises USD5.4 Million in Venture Financing 852

34.9.32 Viseon Raises Additional USD1.87 Million in Venture Financing 853

34.9.33 Suneva Medical Raises USD5 Million in Venture Financing 854

34.9.34 Viseon Raises USD27.6 Million in Venture Financing 855

34.9.35 Virtual Incision Raises USD20 Million in Series B+ Financing 856

34.9.36 Allurion Technologies Raises USD34 Million in Venture Financing 857

34.9.37 OrthAlign Raises USD3.2 Million in Venture Financing 858

34.9.38 Surgimatix to Raise USD1 Million in Venture Financing 859

34.9.39 Mezlight to Raise USD2 Million in Venture Financing 860

34.9.40 G.I. Windows Raises USD14.6 Million in Series A Financing 861

34.9.41 Triple Endoscopy Raises USD1.95 Million in Venture Financing 862

34.9.42 CairnSurgical Raises USD3.3 Million in Venture Financing 863

34.9.43 Venclose Raises USD27 Million in Series C Venture Financing 864

34.9.44 Treasure Valley Urology Raises USD0.04 Million in Venture Financing 865

34.9.45 Discover Echo (Echo Labs) Raises USD3.8 Million in Venture Financing 866

34.9.46 Discover Echo Raises USD1 Million in Venture Financing 867

34.9.47 Minerva Surgical Raises USD10 Million in Venture Financing 868

34.9.48 CapsoVision Raises USD2.9 Million in Venture Financing 869

34.9.49 Recros Medica Raises USD14 Million in Series A Financing 870

34.9.50 ZSX Medical Raises USD0.2 Million in Venture Financing 871

34.9.51 AMB Surgical Raises USD0.6 Million in Venture Financing 872

34.9.52 AMB Surgical Raises USD0.4 Million in Venture Financing 873

34.9.53 Sonavex Raises USD3 Million in Financing 874

34.9.54 CryoConcepts Raises USD0.14 Million in Venture Financing 875

34.9.55 CARLSMED Raises USD0.5 Million in Venture Financing 876

34.9.56 Marblehead Medical Raises USD0.6 Million in Venture Financing 877

34.9.57 Verix Health (Greppo Tech) Raises USD8 Milion in Series A Financing 878

34.9.58 MediView XR Raises USD4.5 Million in Seed Financing 879

34.9.59 Diopsys Raises USD1 Million in Venture Financing 880

34.9.60 Virtual Incision Raises USD7.7 Million in Venture Financing 881

34.9.61 CranioVation Raises USD0.05 Million in Venture Financing 882

34.9.62 Surgical Innovation Associates Raises USD4 Million in Series A Financing 883

34.9.63 Meditrina Raises USD13 Million in Venture Financing 884

34.9.64 Spineology Raises USD7 Million in Venture Financing 885

34.9.65 Infinite Arthroscopy Raises USD1 Million in Venture Financing 886

34.9.66 Instapath Secures USD1.78 Million in Funding 887

34.9.67 Aspero Medical Raises Funds through Seed Financing 888

34.9.68 Sebacia Raises USD4.3 Million in Venture Financing 889

34.9.69 Provisio Medical Raises USD2.3 Million in Venture Financing 890

34.9.70 510 Kardiac Devices Raises USD3 Million in Venture Financing 891

34.9.71 Provisio Medical Raises Additional USD0.7 Million in Venture Financing 892

35 Appendix 893

35.1 Research Methodology 894

35.1.1 Coverage 894

35.1.2 Secondary Research 894

36.1.3 Primary Research 895

35.1.4 Market Modeling and Forecasting 896

35.1.5 Company Share Analysis 897

35.1.6 Distribution Share Analysis 897

35.1.7 Benchmarking 898

35.2 GlobalData Consulting 898

35.3 Contact Us 899

35.4 Disclaimer 899

Frequently asked questions

United States General Surgery Market Outlook to 2025 – Access Instruments, Aesthetic Devices, Aesthetic Lasers and Energy Devices and Others thematic reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States General Surgery Market Outlook to 2025 – Access Instruments, Aesthetic Devices, Aesthetic Lasers and Energy Devices and Others in real time.

  • Access a live United States General Surgery Market Outlook to 2025 – Access Instruments, Aesthetic Devices, Aesthetic Lasers and Energy Devices and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.